Chapman Law Group’s very own Jeremy Belanger was recently quoted by the South Florida Sun Sentinel involving the FDA’s massive case against the for-profit “Sunrise” stem cell company. Judge Ursula Ungaro ruled in favor of the FDA’s lawsuit on Monday against the Florida based company whose treatments blinded at least four of their patients.
When asked for his professional comment Jeremy stated
“While stem cells are an emerging area of medicine, the FDA has had regulatory difficulty in this area. This sends the message that if you are a practitioner who wants to engage with stem cells, you really need to pay attention to what you are doing because patients are getting hurt.”
To read more of the article Click Here